Vima Therapeutics
PrivateLast Round
Series A
Mar 11, 2026
Total Funding Raised
$140M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vima Therapeutics is a biotechnology company developing oral therapeutics designed for the treatment of movement disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vima Therapeutics Comparables
Compare Vima Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Motric Bio | 76% | |
| Addex Therapeutics | 76% | |
| Neurocrine Biosciences | 72% | |
Vima Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 11, 2026 | ||||
| Series A | May 29, 2025 |
Vima Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Access Industries | Series A |
| Frazier Life Sciences | Series A |
| Canaan Partners | Series A |
| Atlas Venture | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2026
Grew 16% QoQ, from 19 to 22 employees.
- Apr 24, 2026
Monthly visitors increased 303% MoM, reaching 2.4K.
Vima Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vima Therapeutics's valuation, stock price, and market status.